Compare ATOM & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOM | KRMD |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.2M | 198.1M |
| IPO Year | 2016 | 2019 |
| Metric | ATOM | KRMD |
|---|---|---|
| Price | $8.81 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 2.2M | 130.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.41 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | $62,000.00 | ★ $41,127,366.00 |
| Revenue This Year | $527.69 | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.89 | $2.51 |
| 52 Week High | $9.59 | $6.61 |
| Indicator | ATOM | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 79.31 | 37.66 |
| Support Level | $2.20 | $3.84 |
| Resistance Level | N/A | $4.34 |
| Average True Range (ATR) | 0.76 | 0.20 |
| MACD | 0.32 | -0.01 |
| Stochastic Oscillator | 84.13 | 12.00 |
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.